Isogenic human mammary epithelial cell lines: Novel tools for target identification and validation: Comprehensive characterization of an isogenic human mammary epithelial cell model provides evidence for epithelial-mesenchymal transition

被引:0
作者
Ulbricht U. [1 ]
Sommer A. [2 ]
Beckmann G. [3 ]
Lutzenberger M. [4 ]
Seidel H. [3 ]
Kreft B. [2 ]
Toschi L. [2 ]
机构
[1] Global Drug Discovery, Global R and D Information, Bayer Pharma AG
[2] Global Drug Discovery, TRG-Oncology/Gynecological Therapy, Bayer Pharma AG, Berlin
[3] Global Drug Discovery, Target Discovery Technologies, Bayer Pharma AG, Berlin
[4] Neurodegenerative Diseases, Robert-Koch-Institute, Berlin
关键词
Cell transformation; neoplastic; Epithelial cells; pathology; Human mammary epithelial cell (HMEC); Immortalization; Isogenic cell line;
D O I
10.1007/s10549-013-2472-7
中图分类号
学科分类号
摘要
Tumorigenesis is a multi-step process involving several consecutive genetic alterations resulting in loss of genomic stability and deregulated signal transduction pathways. To study these deregulated processes in vitro, typically established cancer cell lines derived from primary tumors, ascites, or from metastases are used. However, these cancer cell lines reflect only late stages of the tumorigenic process. To better understand the consequences of the sequential genetic alterations in an in vitro model system, we applied consecutive immortalization and transformation of primary human mammary epithelial cells (HMECs) combining shRNA-mediated knockdown of tumor suppressor genes and overexpression of oncogenes. Thereby, we developed a panel of isogenic HMEC-derived cell lines reflecting the multi-step process of tumorigenesis. The immortalized cell lines have a normal epithelial morphology and proliferate indefinitely and anchorage-dependently. In contrast, the transformed cells exhibit mesenchymal-like morphological changes and strong colony-forming activity in soft agar. SNP array analysis showed that none of the cell lines displayed gross chromosomal aberrations in 80 % of the chromosomes. However, massive changes were observed in some chromosomes of the transformed cells indicating that the transformed phenotype is characterized by chromosomal alterations. The isogenic immortalized and transformed cells described here provide a powerful tool for the in vitro validation of target genes for cancer therapy. © 2013 Springer Science+Business Media New York.
引用
收藏
页码:437 / 456
页数:19
相关论文
共 74 条
  • [1] Hanahan, D., Weinberg, R.A., Hallmarks of cancer: The next generation (2011) Cell, 144 (5), pp. 646-674. , S0092-8674(11)00127-9 21376230 10.1016/j.cell.2011.02.013 1:CAS:528:DC%2BC3MXjsFeqtrk%3D
  • [2] Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100 (1), pp. 57-70
  • [3] Egner, U., Kratzschmar, J., Kreft, B., Pohlenz, H.-D., Schneider, M., The target discovery process (2005) ChemBioChem, 6 (3), pp. 468-479. , DOI 10.1002/cbic.200400158
  • [4] Ikediobi, O.N., Davies, H., Bignell, G., Edkins, S., Stevens, C., O'Meara, S., Santarius, T., Wooster, R., Mutation analysis of 24 known cancer genes in the NCI-60 cell line set (2006) Molecular Cancer Therapeutics, 5 (11), pp. 2606-2612. , DOI 10.1158/1535-7163.MCT-06-0433
  • [5] Machida, Y.J., Chen, Y., Machida, Y., Malhotra, A., Sarkar, S., Dutta, A., Targeted comparative RNA interference analysis reveals differential requirement of genes essential for cell proliferation (2006) Molecular Biology of the Cell, 17 (11), pp. 4837-4845. , DOI 10.1091/mbc.E06-04-0340
  • [6] Vargo-Gogola, T., Rosen, J.M., Modelling breast cancer: One size does not fit all (2007) Nature Reviews Cancer, 7 (9), pp. 659-672. , DOI 10.1038/nrc2193, PII NRC2193
  • [7] Comprehensive molecular portraits of human breast tumours (2012) Nature, 490 (7418), pp. 61-70. , doi: 10.1038/nature11412
  • [8] Di Cristofano, A., Pandolfi, P.P., The multiple roles of PTEN in tumor suppression (2000) Cell, 100 (4), pp. 387-390. , 10693755 10.1016/S0092-8674(00)80674-1
  • [9] Shah, S.P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Aparicio, S., The clonal and mutational evolution spectrum of primary triple-negative breast cancers (2012) Nature, 486 (7403), pp. 395-399. , 10.1038/nature10933 22495314 1:CAS:528:DC%2BC38XmtVersL4%3D
  • [10] Saal, L.H., Holm, K., Maurer, M., Memeo, L., Su, T., Wang, X., Yu, J.S., Parsons, R., PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma (2005) Cancer Research, 65 (7), pp. 2554-2559. , DOI 10.1158/0008-5472-CAN-04-3913